Chemotherapy for Gestational Trophoblastic Disease
Author Information
Author(s): Gillespie A M, Siddiqui N, Coleman R E, Hancock B W
Primary Institution: Gestational Trophoblastic Disease Screening and Treatment Centre, Yorkshire Cancer Research, Weston Park Hospital
Hypothesis
Does central nervous system chemoprophylaxis have a role in treating gestational trophoblastic disease?
Conclusion
The study supports not using prophylactic intrathecal therapy for patients with lung metastases unless there is clinical evidence of CNS involvement.
Supporting Evidence
- 67 out of 69 patients received only intravenous chemotherapy.
- One patient developed a cerebral metastasis after non-compliance with treatment.
Takeaway
The researchers looked at patients with lung cancer and found that giving them extra treatment for the brain wasn't necessary unless there were signs of brain problems.
Methodology
The outcomes of 69 patients with lung metastases were analyzed regarding the use of prophylactic intrathecal chemotherapy.
Limitations
The study is limited by the small number of patients and the non-compliance of one patient affecting the results.
Participant Demographics
Patients with lung metastases from gestational trophoblastic disease.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website